A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
about
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectivesGenomic profiling in luminal breast cancerHormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenProspective Validation of a 21-Gene Expression Assay in Breast CancerPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsOptimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithmsComparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer.A breast cancer gene signature for indolent disease.Biological subtypes of breast cancer: Prognostic and therapeutic implications.The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancerBreast cancer in young women: special considerations in multidisciplinary care.Equivalence of MammaPrint array types in clinical trials and diagnostics.Multigene prognostic tests in breast cancer: past, present, futureBig data and computational biology strategy for personalized prognosis.The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidenceFrom High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.Molecular profiling for breast cancer: a comprehensive review.Long-term impact of the 70-gene signature on breast cancer outcome.Mammographic screening detects low-risk tumor biology breast cancers.Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.Molecular tests as prognostic factors in breast cancer.Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.Hurdles on the road to personalized medicine.Genomic medicine and risk prediction across the disease spectrum.Gene expression-based prognostic and predictive tools in breast cancer.Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers.Biomarker assessment and molecular testing for prognostication in breast cancer.Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Clinical utility of gene-expression signatures in early stage breast cancer.GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW.Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.Internet tools to enhance breast cancer care.
P2860
Q26768119-69FF779B-6331-41EE-81E0-274E92DA3FD0Q26862681-09FF9A5C-A460-42D8-8383-A4CA8C786EBDQ28077637-997AD93B-F9E7-4C28-A8A2-18953504FD6DQ29011698-A6AA7B47-5D84-4057-9E03-3C6E123E5FBAQ30543788-1282683C-C81A-4E3B-848B-D2C6DFC66ADFQ33613591-E16FF480-4419-4F18-9A42-8439BB6D479BQ33651520-61C08882-038A-4530-82AF-E14CBED8DDB0Q33657870-7392323E-7440-49DB-A7C1-D461C36AFA53Q33843780-FB8F1EB7-5B0B-4B38-9D76-98E7051A8533Q34023695-397D4F4F-A0F0-488A-B8B5-60A926A0F68AQ34113489-8EF1730B-E5AE-40AF-BB76-4A465F3EB2B5Q34306522-615C777B-FB02-4844-92D0-5CE560C6178DQ34519347-446540E1-F2B8-4C50-A0BA-496DFFFBABBDQ35018599-E1CFF326-8720-488D-912C-1478C054D355Q36031260-6928748E-2491-4AE0-A02D-F1C5469D891EQ36462893-3213E942-FA3E-45A6-B308-B6EB6FB5A695Q37214217-5B1EBF89-DFEA-4F66-B1FC-05B6134D65B1Q37302484-1B6E4808-18DE-4F06-87CB-77BE97218AEDQ37534934-2DE059DF-1C37-4279-8B1E-7974ED2B22FAQ37583102-88B3137C-D8C2-455F-A6C7-046BF6D1FE87Q37711677-75F3809E-BC39-4D11-9400-C5F420EDAF2FQ38184381-24937BEE-33A1-4507-8175-2E25FAA99197Q38232507-CEFBC829-E84D-460E-9F9B-A20561CBF572Q38250141-8FBAB857-1637-4CFF-8400-ABF290C8D70FQ38322338-CAAD2140-C512-4A4B-8183-B514D69A62DEQ38421414-53D94175-7533-4C47-9E37-680F9D7C720BQ38551397-DB9BC15C-C450-4800-93B8-D5FE475E889FQ38632574-00614C1B-DC30-4F2B-8C06-C19D6A710D90Q38690101-DB029F86-ABE1-4337-88D9-A3242BDC122AQ38696790-2BAC3C1D-57E4-4C6C-8192-B45612DB76D3Q38745404-AAEEFBBF-6715-4D73-9697-D672DD0A9440Q38754717-15517A9C-50D4-4641-B2F2-7D2F7E27A4FDQ38795484-DD610DCD-5FED-49C7-AF34-C7B121DBD3B4Q39007386-9B502DDE-BBB3-4496-AF4E-BD9799E26FBDQ39187437-67C9BB2B-D01D-41E3-9964-4BDF44ED5511Q39532008-4724C8A0-7938-400F-8B0E-88C78D8B788AQ40808798-020B5108-44FC-43A4-89C1-468278AD055DQ41113513-E56FD5C0-64AE-486B-81FC-E0DA08501E2BQ41545259-80147A07-8A43-4708-BF81-86A227280B4CQ42334186-5A4081D0-0819-446C-A8A4-C7BD12B66ADD
P2860
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A prospective evaluation of a ...... he observational RASTER study.
@ast
A prospective evaluation of a ...... he observational RASTER study.
@en
A prospective evaluation of a ...... he observational RASTER study.
@nl
type
label
A prospective evaluation of a ...... he observational RASTER study.
@ast
A prospective evaluation of a ...... he observational RASTER study.
@en
A prospective evaluation of a ...... he observational RASTER study.
@nl
prefLabel
A prospective evaluation of a ...... he observational RASTER study.
@ast
A prospective evaluation of a ...... he observational RASTER study.
@en
A prospective evaluation of a ...... he observational RASTER study.
@nl
P2093
P2860
P356
P1476
A prospective evaluation of a ...... he observational RASTER study.
@en
P2093
C A Drukker
E J T Rutgers
H van Tinteren
J M Bueno-de-Mesquita
J Wesseling
L J van 't Veer
R M H Roumen
P2860
P304
P356
10.1002/IJC.28082
P577
2013-03-04T00:00:00Z